Clinical trial · Interventional
Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers
Kaohsiung Medical University Hospital
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Recent basic and clinical research on the circulating tumor cells (CTCs) in CRC patients takes potential diagnostics, prognostics, and applications into consideration, especially the molecular detection of CTCs in peripheral blood. Moreover, identification of therapeutic targets on CTCs and real-time monitoring of CTCs in cancer patients undergoing systemic therapy are the most important future clinical applications. CTCs measures may be useful to guide change in treatment decisions.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancers | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| microRNAs | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- early recurrence
- description
- find the postoperative early relapse out
- interventionNames
- Genetic: microRNAs
Primary outcomes (1)
- measure
- postoperative early recurrence
- timeFrame
- within 12 months postoperation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age \> 18 y/o 2. Histological / pathologic and image study proved colorectal cancer 3. Patients with adequate tissue for biomarkers analysis 4. Patients voluntary sign informed consent Exclusion Criteria: * Patients who are not met with either one of items which mentioned above.
References
Publications (0)
Data not yet available